The group of 17 radiologists recently purchased and installed a Vue PACS and Vue RIS reporting module with native voice recognition from Carestream Health.
Carestream’s portfolio of tabletop CR systems enables healthcare providers to implement efficient, cost-effective digital x-ray imaging while improving productivity and enhancing patient care.
Carestream Health’s scientific research and its innovations in medical imaging technology will be showcased in six presentations at the annual meeting of the Radiological Society of North America.
The new agreement will see Carestream upgrade and migrate PACS across the country’s 34 hospitals, replacing all hardware with new WinTel platforms configured with the latest CARESTREAM Vue PACS V11software and new compression, storage and retention plans implemented on the National Archives.
The works-in-progress CARESTREAM DRX-Revolution Mobile X-Ray System will offer significant benefits for physicians, radiographers and patients due to its image quality, easy maneuverability and productivity-enhancing features.
With its low acquisition and operating costs, the CS 9300 offers an excellent return on investment and provides practitioners immediate access to CT images, supporting faster, more accurate diagnosis and treatment.
A premium system for to imaging gel, blots, and plates using multiple modalities including chemiluminescence, UV and multi-wavelength fluorescence, and radioisotopic labels – all in a single, easy to use platform.
This affordable CR-based image acquisition and mini-PACS solution performs web-based patient scheduling, fully featured image review and reporting as well as offering flexible archiving options.
Xtreme is powered by an innovative system architecture that provides the ultimate combination of sensitivity, speed and flexibility to meet the most demanding challenges and broadest range of applications for molecular imaging.
Data was drawn from Brighton and Sussex University NHS Trust, previous research by Carestream and expert opinion and the analysis was carried out by London-based Matrix Evidence.